Immunisation Information Systems in the EU and EEA

Immunisation information systems (IIS) are defined as confidential, population-based, computerised databases that record all immunisation doses administered by participating providers to persons residing within a given geopolitical area. At the point of clinical care, they support practitioner decision-making in ensuring appropriate individual vaccination and adherence to applicable policies. At population level, IIS provide aggregate data on vaccinations for use in surveillance and programme operations, and in guiding public health action to improve vaccination rates and reduce vaccine-preventable diseases.

The European Council conclusions on vaccinations from both 2011 and 2014 recommend the adoption of such systems and the World Health Organization's European Vaccine Action Plan 2015–2020 recognises IIS as 'an integral part of well-functioning health systems'. IIS have the potential to improve performance of vaccination programmes and to increase vaccine uptake, but the design, development and implementation of such systems can be challenging for national programme managers. The European Centre for Disease Prevention and Control (ECDC) is currently running activities to support the Member States in establishing IIS. One important initial activity was to gather information about the implementation level and the functionalities of existing immunisation information systems in European Union/European Economic Area (EU/EEA) countries. To do this, ECDC, in close collaboration with subject-matter experts, developed surveys on IIS status and functionalities in EU/EEA countries.

Download: Immunisation Information Systems in the EU and EEA (1.282 KB).

Download from eHealthNews.eu: Immunisation Information Systems in the EU and EEA (2.282 KB).

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...